Therapeutic Area

GLP-1 Receptor Agonist

Therapeutic area intelligence for GLP-1 Receptor Agonist with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.

Signals: 1
Catalysts: 0
Companies: 1

Companies

Pfizer →

Assets

Berobenatide →

Recent signals(1)

ClinicalJune 16, 2026

Pfizer's Berobenatide Shows Promising Phase 2b Results for Monthly Dosing in Obesity Management

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

Obesity →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.